Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab In Patients With Follicular Lymphoma Responding To First Line Induction Therapy In Portugal
Value Health
.
2014 Nov;17(7):A530-1.
doi: 10.1016/j.jval.2014.08.1684.
Epub 2014 Oct 26.
Authors
C Pereira
1
,
Terres C Rubio
2
,
Rodríguez D Rubio
2
Affiliations
1
Roche Farmacêutica Química, Lda., Amadora, Portugal.
2
Health Value, Madrid, Spain.
PMID:
27201679
DOI:
10.1016/j.jval.2014.08.1684
No abstract available